Ketamine: Depression Relief, But Sleep Doesn't Match

A study published on October 6 in Translational Psychiatry revealed that ketamine infusions can improve depression and anxiety symptoms. However, researchers observed that while sleep quality also improved, these sleep benefits did not consistently correlate with the patients' reported mood or anxiety levels.

This finding is significant as it indicates that emotional recovery and sleep improvement may follow different trajectories after ketamine treatment. It highlights the importance of tracking mood, anxiety, and sleep as distinct metrics for assessing recovery. The study assessed 71 individuals with treatment-resistant depression.

While ketamine offers rapid relief within hours for those unresponsive to other treatments, it is used off-label for depression and carries FDA-identified risks. These include potential increases in blood pressure, slowed breathing, misuse, and bladder issues, alongside dissociation. Unmonitored administration can be dangerous.

Esketamine, a related FDA-approved medication called Spravato, also has associated side effects like dizziness, nausea, sleepiness, and dissociation, requiring patients to be monitored for at least two hours post-administration. Clinicians warn against driving or operating machinery until the day after a restful sleep due to potential lingering effects.

Before beginning ketamine treatment, patients are advised to consult with a psychiatrist to discuss medical history, potential medication interactions, monitoring protocols, and follow-up care. Integrating ketamine treatments with psychotherapy is suggested as a strategy to help sustain the benefits of these interventions.